Itolizumab, the monoclonal antibody designed in Cuba, is making its way into the world
The drug has proven effective in patients with psoriasis, COVID-19 and lupus nephritis, inside and outside Cuba.
Tag: Itolizumab
Most Read
-
U.S. not ruling out giving aid to Cuba in face of blackouts and MINREX responds: “it knows what must be done”
-
Congresswoman Barbara Lee to the White House: “Now is the time to help the Cuban people”.
-
Itolizumab, the monoclonal antibody designed in Cuba, is making its way into the world
-
The New York Times publishes letter to Biden demanding end to “brutal” policy on Cuba
-
Kamala Harris and United States’ Cuba policy: a hopeful light?
